IDO1 and cancer: It has to be noted that the blockade of T cell proliferation may not be totally due to tryptophan depletion; it could also involve the metabolites of IDO1-mediated tryptophan breakdown (e.g., kynurenine), which are released from the cancer cells and dendritic cells and elicit detrimental effects on the adjacent T cells with a negative impact on their proliferation.